| scholarly article | Q13442814 |
| P2093 | author name string | Jae-Woon Nah | |
| Mi-Kyeong Jang | |||
| Su Young Chae | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 383-394 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Influence of molecular weight on oral absorption of water soluble chitosans | |
| P478 | volume | 102 |
| Q34371399 | A new controlled-release liquid delivery system based on diclofenac potassium and low molecular weight chitosan complex solubilized in polysorbates |
| Q42808511 | A potential role of IL-6 in the chito-oligosaccharide-mediated inhibition of adipogenesis |
| Q38862820 | Advances in oral delivery of anti-cancer prodrugs |
| Q38291775 | Antidiabetic effect of chitosan oligosaccharide (GO2KA1) is mediated via inhibition of intestinal alpha-glucosidase and glucose transporters and PPARγ expression |
| Q62070922 | Antioxidative Effectiveness of Environment Friendly Functional Biopolymers for Food Applications |
| Q51798087 | Chitooligosaccharides as novel ingredients of fermented foods. |
| Q38472085 | Chitooligosaccharides decreases plasma lipid levels in healthy men. |
| Q91588616 | Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice |
| Q59796126 | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
| Q26778565 | Chitosan and Its Potential Use as a Scaffold for Tissue Engineering in Regenerative Medicine |
| Q57368199 | Chitosan oligosaccharide copolymer micelles with double disulphide linkage in the backbone associated by H-bonding duplexes for targeted intracellular drug delivery |
| Q45304943 | Chitosan rate of uptake in HEK293 cells is influenced by soluble versus microparticle state and enhanced by serum-induced cell metabolism and lactate-based media acidification. |
| Q38566314 | Chitosan-based mucosal adjuvants: Sunrise on the ocean |
| Q34611761 | Chitosan-nanoconjugated hormone nanoparticles for sustained surge of gonadotropins and enhanced reproductive output in female fish |
| Q51172914 | Colon-specific delivery of mesalazine chitosan microspheres. |
| Q57349484 | Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery |
| Q90267369 | Computational Assessment of the Pharmacological Profiles of Degradation Products of Chitosan |
| Q37678321 | Determination of Inorganic Cations and Anions in Chitooligosaccharides by Ion Chromatography with Conductivity Detection |
| Q92257796 | Dietary Chitooligosaccharide Inclusion as an Alternative to Antibiotics Improves Intestinal Morphology, Barrier Function, Antioxidant Capacity, and Immunity of Broilers at Early Age |
| Q56036313 | Dietary fucoidan of Acaudina molpadioides and its enzymatically degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice |
| Q47362437 | Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy |
| Q39764684 | Effect of chitosan on the infectivity of murine norovirus, feline calicivirus, and bacteriophage MS2. |
| Q46929707 | Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2). |
| Q60047632 | Effects of Chitosan Oligosaccharides on Human Blood Components |
| Q88908790 | Effects of chito-oligosaccharide on piglet jejunal explants: an histological approach |
| Q84789425 | Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats |
| Q95262949 | Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems |
| Q33709398 | In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis |
| Q33810854 | In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS) |
| Q33985955 | In vitro permeability enhancement in intestinal epithelial cells (Caco-2) monolayer of water soluble quaternary ammonium chitosan derivatives |
| Q36676143 | Influence of Chitosan Nanoparticles as the Absorption Enhancers on Salvianolic acid B In vitro and In vivo Evaluation |
| Q42583522 | Influence of molecular weight and degree of deacetylation of low molecular weight chitosan on the bioactivity of oral insulin preparations. |
| Q36482330 | Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model |
| Q50048515 | Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo |
| Q39437287 | Lecithin/chitosan nanoparticles for transdermal delivery of melatonin |
| Q37218681 | Low Dosage of Chitosan Supplementation Improves Intestinal Permeability and Impairs Barrier Function in Mice |
| Q37818236 | Macromolecules as taxane delivery systems. |
| Q37065972 | Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2) |
| Q43123738 | Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells |
| Q43052454 | Modulation of in vitro attachment, proliferation and osteogenic differentiation of rat bone-marrow-derived stem cells using different molecular mass chitosans and their blends with gelatin |
| Q35860326 | Modulation of lipid metabolism by mixtures of protamine and chitooligosaccharide through pancreatic lipase inhibitory activity in a rat model |
| Q99207852 | Molar mass effect in food and health |
| Q38448854 | Molecular weight dependent glucose lowering effect of low molecular weight Chitosan Oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model |
| Q47139230 | Nanoencapsulated capsaicin changes migration behavior and morphology of madin darby canine kidney cell monolayers |
| Q57369611 | Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins |
| Q38953677 | Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue |
| Q38215429 | Polyphenol Conjugates and Human Health: A Perspective Review. |
| Q40065170 | Porosity effects of natural latex (Hevea brasiliensis) on release of compounds for biomedical applications |
| Q34576118 | Potential anti-HIV agents from marine resources: an overview |
| Q64900753 | Preparation, Physicochemical Properties and Hemocompatibility of Biodegradable Chitooligosaccharide-Based Polyurethane. |
| Q38286203 | Safety and toxicity concerns of orally delivered nanoparticles as drug carriers |
| Q38013190 | Strategies for non-invasive delivery of biologics |
| Q49953574 | Succinylated chitosan derivative has local protective effects on intestinal inflammation. |
| Q57354497 | Synthesis and characterization of thermosensitive nanoparticles based on PNIPAAm core and chitosan shell structure |
| Q57354732 | Synthesis and micellization of block copolymer based on host–guest recognition and double disulphide linkage for intracellular drug delivery |
| Q35547243 | The development of poly-L-arginine-coated liposomes for gene delivery |
| Q36938083 | The effect of chitooligosaccharides on oleic acid-induced lipid accumulation in HepG2 cells |
| Q51186895 | The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. |
| Q35005613 | The safety of chitosan as a pharmaceutical excipient |
| Q37679957 | What should be considered on design of a colon-specific prodrug? |
Search more.